The potential of exome sequencing of paired colorectal tumors and synchronous liver metastases to improve treatment.

IF 1.9 4区医学 Q3 PHARMACOLOGY & PHARMACY

Pharmacogenomics Pub Date : 2023-08-01 Epub Date: 2023-09-28 DOI:10.2217/pgs-2023-0158

Viktor Hlaváč, Petr Holý, Pavel Souček

引用次数: 0

Abstract

Tweetable abstract Sequencing exomes of synchronous and metachronous liver metastases of colorectal cancer has potential to enhance treatment, since they can have molecular profiles distinct from primary tumors.

查看原文本刊更多论文

配对结直肠肿瘤和同步肝转移的外显子组测序对改善治疗的潜力。

推特摘要癌症同步和异时性肝转移的外显子测序有可能加强治疗，因为它们可以具有不同于原发性肿瘤的分子特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacogenomics 医学-药学

CiteScore

3.40

自引率

9.50%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.